Company

News

News and Press Releases

Ensho and Novartis Collaborate to Improve Awareness of IL-1 Mediated Autoinflammatory Diseases in Canada

01 August 2022

Ensho Announces Real World Study to Develop a Predictive Algorithm for Fabry Disease

25 July 2022

Ensho Announces the REVEAL Study to Assess the Accuracy and Clinical Utility of the H2FPEF and HFA-PEFF Algorithms in Screening for HFpEF in Community Cardiology

03 March 2022

Validation Study of the Apollo aEDC System for Cardiology Real World Evidence to be Presented at ISPOR 2022

25 February 2022

Research on the Feasibility of Developing Computing Algorithms to Analyze EMR Data for Early Detection of ALS to be Presented at 32nd International Symposium on ALS/MND

24 August 2021

Canadian Journal of Cardiology Publishes Abstract of Study Assessing the Accuracy of the Apollo aEDC System in Extracting Clinical Characteristics of Heart Failure Patients

18 October 2021

Ensho Announces a Prospective Observational Study to Determine the Clinical Utility of CA-4F in a Community Cardiology Setting

17 August 2021

Ensho Health Secures ISO 13485:2016 Certification for Developing Medical Device Software

21 July 2021

Ensho Health Issued a Medical Device Establishment License by Health Canada

28 April 2021